Contineum Therapeutics

CTNM · NASDAQ

$8.46+$1.02 (+13.71%)TodayMarket closed ·
Prev close $7.44

Who owns CTNM

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 46.4% of CTNM’s shares.

  • Montanova Capital, LLC7.6%
  • Janus Henderson Investors7.3%
  • Johnson & Johnson Innovation-JJDC, Inc.5.3%
  • BlackRock Institutional Trust Company, N.A.5.0%
  • Next 6 largest institutions21.2%
  • All other shareholders53.6%
Top institutional holders of CTNM
HolderShares% of shares
Montanova Capital, LLC2.84M7.60%
Janus Henderson Investors2.73M7.31%
Johnson & Johnson Innovation-JJDC, Inc.1.98M5.29%
BlackRock Institutional Trust Company, N.A.1.89M5.04%
Franklin Advisers, Inc.1.84M4.92%
Balyasny Asset Management LP1.52M4.07%
Vanguard Capital Management, LLC1.32M3.53%
Perceptive Advisors LLC1.26M3.36%
Fidelity Management & Research Company LLC1.04M2.78%
Millennium Management LLC931.71K2.49%

Largest mutual fund holders

Top mutual fund holders of CTNM
HolderShares% of shares
Franklin Templeton Investment Funds -Biotechnology Discovery1.16M3.11%
Vanguard Total Stock Market Index Fund982.26K2.63%
Franklin Biotechnology Discovery Fund676.12K1.81%
iShares Russell 2000 ETF662.05K1.77%
Fidelity Select Health Care Portfolio450.00K1.20%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.18M (13 trades) of CTNM on the open market, with no buys.

Latest CTNM insider transactions
InsiderTypeSharesValue
Stengone Carmine N.Option exercise2.50K—
Stengone Carmine N.Sale2.50K$41.14K
Stengone Carmine N.Option exercise2.50K$2.52K
Stengone Carmine N.Option exercise2.50K—
Stengone Carmine N.Sale2.50K$40.03K
Stengone Carmine N.Option exercise2.50K$2.52K
Lorrain Daniel S.Option exercise25—
Lorrain Daniel S.Sale25$400
Lorrain Daniel S.Option exercise25$25
Lorrain Daniel S.Option exercise1.01K—

Short interest

Settled Sep 30, 2026

Shares short
3.07M
Days to cover
3.62
% of shares outstanding
8.20%
Average daily volume
847.47K
Change since last report
+25.5%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.